HLA-DRB1*03, but not the TNFA-308 promoter gene polymorphism, confers protection against fistulising Crohn's disease

Immunogenetics

Volumn 47, Issue 6, 1998, Pages 451-455

  Bouma, Gerd ^a,c   Poen, Alexander C ^a   García González, M Asunción ^a   Schreuder, Geziena M Th ^b   Felt Bersma, Richelle J F ^a   Meuwissen, Stephan G M ^a   Peña, A Salvador ^a  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^b LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^c NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

Author keywords

Crohn's disease; DRB1; Fistula; HLA association; TNF polymorphism

Indexed keywords

HLA DR ANTIGEN; TUMOR NECROSIS FACTOR ALPHA; HLA-DRB1 ANTIGEN;

ANUS FISTULA; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CROHN DISEASE; FEMALE; GENE LINKAGE DISEQUILIBRIUM; GENETIC POLYMORPHISM; HUMAN; IMMUNOGENETICS; MALE; PHENOTYPE; PRIORITY JOURNAL; PROMOTER REGION; RISK; ALLELE; GENETICS;

FISTULA;

ALLELES; CROHN DISEASE; FEMALE; HLA-DR ANTIGENS; HUMANS; MALE; POLYMORPHISM, GENETIC; PROMOTER REGIONS (GENETICS); TUMOR NECROSIS FACTOR-ALPHA;

EID: 0031596661     PISSN: 00937711     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002510050382     Document Type: Article

References (31)

1. Aeberhard, P., Berchtold, W., Riedtmann, H.J., and Stadelmann, G. Surgical recurrence of perforating and nonperforating Crohn's disease. Dis Colon Rectum 39: 80-87, 1996
2. Bayless, T.M., Tokayer, A.Z., Polito II, J.M., Quaskey, S.A., Mellits, E.D., and Harris, M.L. Crohn's disease: concordance for site and clinical type in affected family members - potential hereditary influences. Gastroenterology 111: 573-579, 1996
3. Bouma, G., Crusius, J.B.A., Oudkerk Pool, M., Kolkman, J.J., von Blomberg, B.M.E., Kostense, P.J., Giphart, M.J., Schreuder, G.M.T., Meuwissen, S.G.M., and Peña, A.S. Secretion of tumor necrosis factor alpha and lymphotoxin alpha in relation to TNF gene polymorphisms and HLA-DR alleles. Relevance for Inflammatory Bowel Disease. Scand J Immunol 43: 456-463, 1996
4. Bouma, G., Oudkerk Pool, M., Cruisius, J.B.A., Schreuder, G.M.T., Hellemans, H.P.R., Meijer, B.U.G.A., Kostense, P.J., Giphart, M.J., Meuwissen, S.G.M., and Peña, A.S. Evidence for genetic heterogeneity in IBD. HLA genes in the predisposition to suffer from ulcerative colitis and Crohn's disease. Clin Exp Immunol 109: 175-179, 1997
5. Brinkman, B.M.N., Giphart, M.J., Verhoef, A., Kaijzel, E.L., Naipal, A.M.I.H., Daha, M.R., Breedveld, F.C., and Verweij, C.L. Tumor necrosis factor α -308 gene variants in relation to major histocompatibility complex alleles and Felty's syndrome. Hum Immunol 41: 259-266, 1994
6. Colombel, J.F., Grandbastien, B., Gower-Rousseau, C., Plegat, S., Evrard, J.P., Dupas, J.L., Gendre, J.P., Modigliani, R., Belaiche, J., Hostein, J., Hugot, J.P., van Kruiningen, H., and Cortot, A. Clinical characteristics of Crohn's disease in 72 families. Gastroenterology 111: 604-607, 1996
7. D'Alfonso, S. and Momigliano Richiardi, P. A polymorphic variation in a putative regulation box of the TNFA promoter region. Immunogenetics 39: 150-154, 1994
8. Danze, P.M., Colombel, J.F., Jacquot, S., Loste, M.N., Heresbach, D., Ategbo, S., Khamassi, S., Perichon, B., Semana, G., Charron, D., and Cezard, J.P. Association of HLA class II genes with susceptibility to Crohn's disease. Gut 39: 69-72, 1996
9. Duerr, R.H. Genetics of inflammatory bowel disease. Inflammatory Bowel Diseases 2: 48-60, 1996
10. Forcione, D.G., Sands, B., Isselbacher, K.J., Rustgi, A., Podolsky, D.K., and Pillai, S. An increased risk of Crohn's disease in individuals who inherit the HLA class II DRB3*0301 allele. Proc Natl Acad Sci USA 93: 5094-5098, 1996
11. Fujita, K., Naito, S., Okabe, N., and Yao, T. Immunological studies in Crohn's disease. I. Associations with HLA systems in the Japanese. J Clin Lab Immunol 14: 99-102, 1984
12. Hugot, J.P., Laurent-Puig, P., Gower-Rousseau, C., Olson, J.M., Lee, J.C., Beaugerie, L., Naom, I., Dupas, J.L., Van Gossum, A., GETAID, Orholm, M., Bonaitti-Pellie, C., Weissenbach, J., Mathew, C.G., Lennard-Jones, J.E., Cortot, A., Colombel, J.F., and Thomas, G. Mapping of a susceptibility locus for Crohn's disease on chromosome 16. Nature 379: 821-823, 1996
13. Jacob, C.O., Fronek, Z., Lewis, G.D., Koo, M., Hansen, J.A., and McDevitt, H.O. Heritable major histocompatibility complex class II-associated differences in production of tumor necrosis factor alpha: relevance to genetic predisposition to systemic lupus erythematosus. Proc Natl Acad Sci USA 87: 1233-1237, 1990
14. Kobayashi, K., Atoh, M., Yagita, A., Konoeda, Y., Inoko, H., Ando, A., and Sekiguchi, S. Crohn's disease in the Japanese is associated with the HLA-DRw53. Exp Clin Immunogenet 7: 101-108, 1990
15. Lennard-Jones, J.E. Classification of inflammatory bowel disease. Scand J Gastroenterol 24 (Suppl 170): 2-6, 1989
16. Lunniss, P.J., Barker, P.G., Sultan, A.H., Armstrong, P., Reznek, R.H., Bartram, C.I., Cottam, K.S., and Phillips, R.K. Magnetic resonance imaging of fistula-in-ano. Dis Colon Rectum 37: 708-718, 1994
17. Matake, H., Okabe, N., Naito, S., and Yao, T. An HLA study on 149 Japanese patients with Crohn's disease. Gastroenterologica Japonica 27: 496-501, 1992
18. McGuire, W., Hill, A.S.V., Allsop, C.E.M., Greenwood, B.M., and Kwiatkowski, D. Variation in the TNF-alpha promoter region associated with susceptibility to cerebral malaria. Nature 371: 508-511, 1994
19. Mehra, N.K., Verduyn, W., Taneja, V. Drabbels, J., Singh, S.P.N., and Giphart, M.J. Analysis of HLA-DR2-associated polymorphisms by oligonucleotide hybridization in an Asian Indian population. Hum Immunol 32: 246-253, 1991
20. Nakajima, A., Matsuhashi, N., Kodama, T., Yazaki, Y., Takazoe, M., and Kimura, A. HLA-linked susceptibility and resistance genes in Crohn's disease. Gastroenterology 109: 1462-1467, 1995
21. Poen, A.C., Felt-Bersma, R.J.F., Eijsbouts, Q.A.J., Bleichrodt, R., Cuesta, M.A., and Meuwissen, S.G.M. Hydrogen peroxide assisted transanal ultrasound in the diagnosis of fistula-in-ano. Gut 41 (Suppl 3): A17, 1997
22. Reinshagen, M., Loeliger, C., Kuehnl, P., Weiss, U., Manfras, B.J., Adler, G., and Boehm, B.O. HLA class II gene frequencies in Crohn's disease: a population based analysis in Germany. Gut 38: 538-542, 1996
23. Sachar, D.B., Andrews, H.A., Farmer, R.G., Pallone, F., Peña, A.S., Prantera, C., and Rutgeerts, P. Proposed classification of patients subgroups in Crohn's disease. Working team report. Gastroenterol Int 5: 141-154, 1992
24. Satsangi, J., Parkes, M., Louis, E., Hashimoto, L., Kato, M., Welsh, K., Terwilliger, J.D., Lathrop, G.M., Bell, J.I., and Jewell, D.P. Two stage genome-wide search in inflammatory bowel disease provides evidence for susceptibility loci on chromosomes 3, 7 and 12. Nat Genet 14: 199-202, 1996a
25. Satsangi, J., Welsh, K.I., Bunce, M., Julier, C., Farrant, J.M., Bell, J.I., and Jewell, D.P. Contribution of genes of the major histocompatibility complex to susceptibility and disease phenotype in inflammatory bowel disease. Lancet 347: 1212-1217, 1996b
26. Steinhart, A.H. and McLeod, R.S. Medical and surgical management of perianal Crohn's disease. Inflammatory Bowel Diseases 2: 200-210, 1996
27. Toyoda, H., Wang, S.J., Yang, H.Y., Redford, A., Magalong, D., Tyan, D., McElree, C.K., Pressman, S.R., Shanahan, F., Targan, S.R., and Rotter, J.I. Distinct associations of HLA class II genes with Inflammatory Bowel Disease. Gastroenterology 104: 741-748. 1993
28. Van Dullemen, H.M., van Deventer, S.J.H., Hommes, D.W., Bijl, H.A., Jansen, J., Tytgat, G.N.J., and Woody, J. Treatment of Crohn's disease with anti-tumor necrosis factor chimeric monoclonal antibody (cA2). Gastroenterology 109: 129-135, 1995
29. Verduyn, W., Doxiadis, I.I.N., Anholts, J., Drabbels, J.J.M., Naipal, A., D'Amaro, J., Persijn, G.G., Giphart, M.J., and Schreuder, G.M.T. Biotinylated DRB sequences-specific oligonucleotides. Comparison to serologic HLA-DR typing of organ donors in Eurotransplant. Hum Immunol 37: 59-67, 1993
30. Wilson, A.G., de Vries, N., Pociot, F., di Giovine, F.S., van der Putte, L.B.A., and Duff, G.W. An allelic polymorphism within the human tumor necrosis factor alpha promoter region is strongly associated with HLA A1, B8, and DR3 alleles. J Exp Med 177: 557-560, 1993
31. Wilson, A.G., Symons, J.A., McDowell, T.L., McDevitt, H.O., and Duff, G.W. Effects of a polymorphism in the human tumor necrosis factor a promoter on transcription activation. Proc Natl Acad Sci USA 94: 3195-3199, 1997